These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate: a double-blind placebo-controlled randomized study. Kaleli S; Aydin Y; Erel CT; Colgar U Fertil Steril; 2001 Apr; 75(4):718-23. PubMed ID: 11287025 [TBL] [Abstract][Full Text] [Related]
46. The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women. Bain CA; Walters MR; Lees KR; Lumsden MA Hum Reprod; 2004 Oct; 19(10):2411-4. PubMed ID: 15284214 [TBL] [Abstract][Full Text] [Related]
47. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
48. Vitamin B6 in the treatment of pre-menstrual mastalgia. Smallwood J; Ah-Kye D; Taylor I Br J Clin Pract; 1986 Dec; 40(12):532-3. PubMed ID: 3307864 [No Abstract] [Full Text] [Related]
49. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Maddocks S; Hahn P; Moller F; Reid RL Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587 [TBL] [Abstract][Full Text] [Related]
50. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study. Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640 [TBL] [Abstract][Full Text] [Related]
51. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Zamani M; Neghab N; Torabian S Acta Med Iran; 2012; 50(2):101-6. PubMed ID: 22359078 [TBL] [Abstract][Full Text] [Related]
52. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. Horrobin DF J Reprod Med; 1983 Jul; 28(7):465-8. PubMed ID: 6350579 [TBL] [Abstract][Full Text] [Related]
53. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620 [TBL] [Abstract][Full Text] [Related]
55. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial. Chan DM; Cheung KW; Yung SS; Lee VC; Li RH; Ng EH Trials; 2016 Aug; 17(1):408. PubMed ID: 27534747 [TBL] [Abstract][Full Text] [Related]
56. Clinical uses of progestational agents in the endocrine department of Chelsea Hospital for Women. Osmond-Clarke F Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):522-5. PubMed ID: 5534330 [No Abstract] [Full Text] [Related]
58. Duphaston depot, a new long-acting progestogen. Schellen AM Bull Soc R Belge Gynecol Obstet; 1969; 39(4):327-31. PubMed ID: 5408050 [No Abstract] [Full Text] [Related]
59. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria. Steinberg S; Annable L; Young SN; Liyanage N Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042 [TBL] [Abstract][Full Text] [Related]
60. Depression in men and women. Brush MG; Taylor RW Br Med J; 1977 Dec; 2(6100):1479-80. PubMed ID: 563276 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]